FORM OF PLEDGE AGREEMENTPledge Agreement • April 1st, 2024 • HCW Biologics Inc. • Pharmaceutical preparations • New York
This PLEDGE AGREEMENT, dated as of March 28, 2024 (as the same may be amended, supplemented and/or otherwise modified from time to time, this “Agreement”), is entered into by and between HCW BIOLOGICS INC., a Delaware Corporation (“Grantor”), Mercedes M. Sellek, P.A., a Florida corporation (together with its assigns, the “Escrow Agent”),and the other Noteholders (as defined below). The Grantor, The Escrow Agent, and the Noteholders may be referred to individually as a “Party” and collectively the “Parties.”
FORM OF ESCROW AGREEMENTEscrow Agreement • April 1st, 2024 • HCW Biologics Inc. • Pharmaceutical preparations • Florida
THIS ESCROW AGREEMENT dated as of March 28, 2024 (as the same may be amended, supplemented and/or otherwise modified from time to time ( the “Escrow Agreement”), is made and entered into by and among the Noteholders listed on “Exhibit A” attached to this Escrow Agreement as secured parties (collectively the “Noteholders”),HCW BIOLOGICS INC., a Delaware Corporation (the “HCW”), (Noteholders and HCW are sometimes collectively referred to herein as the “Parties”), and Mercedes M. Sellek, P.A., a Florida corporation,as escrow agent (the “Escrow Agent”).
FORM OF SENIOR SECURED NOTE PURCHASE AGREEMENTSenior Secured Note Purchase Agreement • April 1st, 2024 • HCW Biologics Inc. • Pharmaceutical preparations • New York
This Senior Secured Note Purchase Agreement (this “Agreement”) is made as of March 28, 2024 (the “Closing Date”) by and between HCW Biologics Inc., a Delaware corporation (the “Company”), and each of the purchasers listed on Exhibit B attached to this Agreement (each a “Purchaser” and together the “Purchasers”).
